This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Albany Molecular Research Inc (AMRI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 47.00M 175.93M 23.29M 19.98M
Receivables 76.70M 59.74M 50.68M 40.66M
Inventories 49.88M 31.99M 28.22M 26.00M
Other Current Assets 13.38M 0.00 0.00 0.00
Total Current Assets 191.01M 279.02M 113.42M 100.56M
Property, Plant & Equipment, Gross 165.48M 294.76M 294.49M 296.63M
Accumulated Depreciation & Depletion n.a. 166.99M 158.97M 146.83M
Property, Plant & Equipment, Net 165.48M 127.78M 135.52M 149.80M
Intangibles 0.00 3.04M 3.06M 2.98M
Other Non-Current Assets 163.47M 33.38M 7.33M 2.36M
Total Non-Current Assets 328.94M 166.25M 149.44M 162.51M
Liabilities & Shareholder Equity
Total Assets 519.95M 445.27M 262.86M 263.07M
Accounts Payable n.a. 24.18M 18.19M 20.42M
Short Term Debt 0.00 1.02M 776.00K 2.84M
Other Current Liabilities 48.69M 12.70M 11.64M 4.08M
Total Current Liabilities 48.69M 43.90M 35.99M 37.98M
Long Term Debt 159.98M 123.14M 7.23M 3.00M
Deferred Income Taxes n.a. 631.00K 753.00K 733.00K
Other Non-Current Liabilities 69.46M 31.90M 12.76M 14.92M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 229.44M 155.66M 20.74M 18.66M
Total Liabilities 278.13M 199.56M 56.72M 56.63M
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 241.82M 245.70M 206.14M 206.43M
Common Par n.a. 370.00K 363.00K 360.00K
Additional Paid In Capital 0.00 235.81M 207.78M 206.07M
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings 0.00 87.86M 75.18M 78.95M
Treasury Stock n.a. -67.05M -66.89M -66.89M
Other Equity Adjustments 241.82M -11.28M -10.30M -12.07M
Total Capitalization 401.80M 368.84M 213.37M 209.44M
Total Equity 241.82M 245.70M 206.14M 206.43M
Total Liabilities & Stock Equity 519.95M 445.27M 262.86M 263.07M
Total Common Shares Outstanding 32.61M 31.60M 30.92M 30.60M
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 5.42M 5.41M 5.41M
Basic Weighted Shares Outstanding n.a. 30.91M 30.32M 29.96M
Diluted Weighted Shares Outstanding n.a. 30.91M 30.32M 29.96M
Number of Employees NA 1282 1329 1389
Number of Part-Time Employees NA 0 0 0
AMRI News

AMRI Albany Molecular Research Inc

Analysts Ratings for AMRI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET AMRI ANALYST REPORT

Brokerage Partners

AMRI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs